Clinical Trials Logo

Brain Injuries clinical trials

View clinical trials related to Brain Injuries.

Filter by:

NCT ID: NCT04176640 Active, not recruiting - Pediatric Clinical Trials

Quantifying Brain Injury on Computed Tomography in Hospitalized Children

QBIct
Start date: October 20, 2015
Phase:
Study type: Observational

Lay Summary: To evaluate a novel early diagnostic tool for hospitalized children with traumatic brain injury. The Problem: Children who present with decreased level of consciousness after injury require urgent medical attention determined by the type and the severity of injury. Unfortunately, history and physical findings are often unreliable in the first hours after hospitalization, the period in which urgent management decisions must be made for their treatment. The Solution: A promising tool developed for measuring detectable evidence of traumatic brain injury on routine brain scans. The tool combines features invisible to the human eye but detectable by computer software with expert knowledge.This study will evaluate how well the tool can perform in a real health care setting. It is believed that it will greatly improve the efficacy and quality of care provided to children after traumatic brain injury.

NCT ID: NCT04171960 Active, not recruiting - Clinical trials for Traumatic Brain Injury

Clinical Evaluation of the i-STAT TBI Test

Start date: July 30, 2020
Phase:
Study type: Observational

The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI). Patients will be asked to provide a blood sample.

NCT ID: NCT04169191 Active, not recruiting - Birth Asphyxia Clinical Trials

Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia

SANE-02
Start date: September 19, 2019
Phase: Phase 1
Study type: Interventional

The investigators will determine the maximum tolerable dose of sildenafil and establish the pharmacokinetic and pharmacodynamic profile of sildenafil in human asphyxiated neonates treated with hypothermia. They will use a 3+3 design to escalate the sildenafil dose up to 6 mg/kg/day (3mg/kg/dose q12h) in asphyxiated neonates demonstrating brain injury despite hypothermia treatment and assess whether we observe any beneficial effects of sildenafil on their brain and cardiopulmonary hemodynamics, without causing serious adverse events

NCT ID: NCT04168164 Completed - Clinical trials for Acquired Brain Injury

Aquatic Therapy in Patients With Adquired Brain Injury.

Start date: January 7, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to compare the relative effectiveness of three different treatment groups for improvements of postural control and for improvements of balance in these patients using aquatic therapy.

NCT ID: NCT04167891 Completed - Cardiac Arrest Clinical Trials

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Out of Hospital Cardiac Arrest

AfterROSC1
Start date: August 1, 2020
Phase:
Study type: Observational

Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.

NCT ID: NCT04166617 Active, not recruiting - Stroke Clinical Trials

Assessment Effectiveness of the Leap Motion Capture® System on the Functionality of the Upper Limb in Acquired Brain Injury

Start date: November 12, 2019
Phase: N/A
Study type: Interventional

The affectedness of the motor control of the upper limb, particulary, the hand and/or fingers, appears in many neurological diseases, what is going to impact on the functionality of the subject. The use of new technologies in the rehabilitation environment, has the target to reduce the impact on the disabling conditions. So that, the goal of this investigation is to evaluate the system use effectiveness of the Leap Motion Controller® in the treatment on the upper limb on patients with neurological disease.

NCT ID: NCT04161573 Recruiting - Clinical trials for Traumatic Brain Injury

Irony Comprehension Ability of Chinese Speaking Patients With TBI

Start date: October 10, 2019
Phase:
Study type: Observational

This study aims at understanding irony comprehension ability of Chinese speaking patients with TBI through a series of self-made stories. Each story contains two characters having a conversation, and one of them would give a figurative (which is, ironic) or literal statement at the end of the story. The participants are asked to figure out its meaning.

NCT ID: NCT04157634 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Prediction of Neurological Outcome of Children After a Traumatic Brain Injury Based on an Integrated Predictive Model

Start date: January 2020
Phase: N/A
Study type: Interventional

This study aims to develop a integrated predictive model based on serum biomarkers, HRV, and an innovative computerized classifier output, to predict the patient long term neurological outcome after a moderate or severe TBI in children.

NCT ID: NCT04152681 Recruiting - Radiation Injuries Clinical Trials

Effect and Safety of Apatinib on Radiation-Induced Brain Injury

Start date: October 17, 2019
Phase: Phase 2
Study type: Interventional

Purpose: This early phase 2 clinical trial aims to evaluate the therapeutic effects and safety of apatinib in radiation-induced brain injury. Further study details as provided by Sun Yet-sen Memorial Hospital, Sun Yat-sen University / Yamei Tang. Primary outcome measure: The proportion of patients with an objective response defined as ≥ 25% reduction in brain edema volume on MR fluid attenuated inversion recovery (FLAIR) images.

NCT ID: NCT04144972 Recruiting - Pain, Postoperative Clinical Trials

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

Start date: October 24, 2019
Phase: N/A
Study type: Interventional

Chronic pain affects 1 in 4 US adults, and many cases are resistant to almost any treatment. Deep brain stimulation (DBS) holds promise as a new option for patients suffering from treatment-resistant chronic pain, but traditional approaches target only brain regions involved in one aspect of the pain experience and provide continuous 24/7 brain stimulation which may lose effect over time. By developing new technology that targets multiple, complimentary brain regions in an adaptive fashion, the investigators will test a new therapy for chronic pain that has potential for better, more enduring analgesia.